Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126480) titled 'A Radiomics-Transformer Fusion Model for Identifying Beneficial Subgroups of Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab' on June 9.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Hepatocellular Carcinoma
Intervention:
Gold Standard:Diagnosed with hepatocellular carcinoma (HCC) clinically and/or pathologically per the Chinese Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2024 Edition)
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment:...